科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
未登录
返回
C
Catherine Copley‐Merriman
research triangle institute
25
H指数
107
论文数
2.2K
被引数
0
相关解读
订阅
收录论文
29
发表时间
发表时间
IF
被引数
SIMILARITIES & DIFFERENCES IN GLOBAL VALUE DOSSIER (GVD) AND ACADEMY OF MANAGED CARE PHARMACY (AMCP) DOSSIER DEVELOPMENT
VALUE IN HEALTH
IF
6
2019-05-01
0
OA
AI
Khan, S.; Mordin, M.; Barrows, S. M.; Copley-Merriman, C.
分享
收藏
A SYSTEMATIC REVIEW OF UTILITY ESTIMATES IN MELANOMA IN THE ADJUVANT SETTING
VALUE IN HEALTH
IF
6
2018-10-01
0
OA
AI
Masaquel, C.; Rothwell, B.; Bhaila, R.; Copley-Merriman, C.; Wolowacz, S.; Aguiar-Ibanez, R.; Patel, N.; Liu, F. X.
分享
收藏
HTA AND REIMBURSEMENT CONSIDERATIONS FOR RARE DISEASES IN EUROPEAN MARKETS: WHAT ARE THE IMPLICATIONS FOR MANUFACTURERS?S?
VALUE IN HEALTH
IF
6
2018-10-01
1
OA
AI
Heyes, A. E.; McBride, D.; Pearson, I; Copley-Merriman, C.
分享
收藏
COMPARING LITERATURE REVIEW REQUIREMENTS FOR REIMBURSEMENT SUBMISSIONS ACROSS THE GLOBE
VALUE IN HEALTH
IF
6
2018-05-01
0
OA
AI
Fernandez, M. M.; Khan, S.; Mordin, M.; Copley-Merriman, C.; McBride, D.
分享
收藏
SYSTEMATIC LITERATURE REVIEW (SLR) OF SEQUENCING OF ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
VALUE IN HEALTH
IF
6
2018-05-01
1
OA
AI
Barrows, S. M.; Wright, K.; Copley-Merriman, C.; Kaye, J. A.; Chioda, M. D.; Wiltshire, R.; Torgersen, K. M.; Masters, E. T.
分享
收藏
SIMILARITIES AND DIFFERENCES IN EUROPEAN HTA EVIDENCE REQUIREMENTS: ONE FOR ALL OR ONE FOR NONE?
VALUE IN HEALTH
IF
6
2018-05-01
0
OA
AI
Mordin, M.; Fernandez, M. M.; Pearson, I; Copley-Merriman, C.; McBride, D.
分享
收藏
The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH
IF
3.1
2016-10-15
36
PRE
AI
Winnette, Randall; Hess, Lisa M.; Nicol, Steven J.; Tai, Datchen Fritz; Copley-Merriman, Catherine
分享
收藏
Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH
IF
3.1
2016-09-15
21
PRE
AI
Copley-Merriman, Catherine; Zelt, Susan; Clark, Marci; Gnanasakthy, Ari
分享
收藏
BENEFITS OF PATIENT-REPORTED OUTCOMES IN DERMATOLOGY DRUG DEVELOPMENT
VALUE IN HEALTH
IF
6
2015-05-01
1
OA
AI
Copleymerriman, C.; Zelt, S.; Clark, M.; Gnanasakthy, A.
分享
收藏
Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union
HEALTH AND QUALITY OF LIFE OUTCOMES
IF
3.4
2014-07-04
25
OA
AI
Clark, Marci J.; Harris, Nimanee; Griebsch, Ingolf; Kaschinski, Dagmar; Copley-Merriman, Catherine
分享
收藏
PAYER NEEDS IN EMERGING MARKETS: HOW SHOULD THESE NEEDS BE INCLUDED IN DERMATOLOGY DRUG DEVELOPMENT PLANS?
VALUE IN HEALTH
IF
6
2014-05-01
0
OA
AI
Copley-Merriman, C.; Zelt, S.; Stone, G.; Barrows, S.; Mordin, M.; Hogue, S.
分享
收藏
SYSTEMATIC LITERATURE REVIEWS AT THE HEART OF HEALTH TECHNOLOGY ASSESSMENT: A COMPARISON ACROSS MARKETS
VALUE IN HEALTH
IF
6
2013-11-01
0
OA
AI
Rycroft, C. E.; Fernandez, M.; Copley-Merriman, C.
分享
收藏
SYSTEMATIC LITERATURE REVIEW OF UTILITIES RELATING TO PATIENTS WITH TYPE-2 DIABETES MELLITUS EXPERIENCING A STROKE OR MYOCARDIAL INFARCTION
VALUE IN HEALTH
IF
6
2013-05-01
0
OA
AI
Brennan, V. K.; Colosia, A. D.; Copley-Merriman, C.; Hass, B.; Palencia, R.
分享
收藏
SYSTEMATIC LITERATURE REVIEW OF THE TEMPORAL RELATIONSHIP BETWEEN NSAID USE AND GASTROINTESTINAL, CARDIOVASCULAR, OR RENAL EVENTS
VALUE IN HEALTH
IF
6
2013-05-01
1
OA
AI
Copley-Merriman, C.; Olanrewaju, O.; Hogue, S.
分享
收藏
SURGICAL INNOVATION: DO WE NEED A MORE BALANCED FRAMEWORK FOR EVIDENCE?
VALUE IN HEALTH
IF
6
2013-05-01
0
OA
AI
Mordin, M.; Copley-Merriman, C.; Mauskopf, J. A.; Sweeney, C.; Bhattacharyya, S. K.; Farup, C.; Beach, W.; Higgins, L.; McIntyre, L.
分享
收藏
SYSTEMATIC LITERATURE REVIEW OF COSTS RELATED TO PATIENTS WITH TYPE-2 DIABETES MELLITUS EXPERIENCING A STROKE OR MYOCARDIAL INFARCTION
VALUE IN HEALTH
IF
6
2013-05-01
0
OA
AI
Brennan, V. K.; Colosia, A. D.; Copley-Merriman, C.; Hass, B.; Palencia, R.
分享
收藏
Reasons for Rejection of Patient-Reported Outcome Label Claims: A Compilation Based on a Review of Patient-Reported Outcome Use among New Molecular Entities and Biologic License Applications, 2006-2010
VALUE IN HEALTH
IF
6
2012-05-01
40
OA
AI
DeMuro, Carla; Clark, Marci; Mordin, Margaret; Fehnel, Sheri; Copley-Merriman, Catherine; Gnanasakthy, Ari
分享
收藏
A Review of Patient-Reported Outcome Labels in the United States: 2006 to 2010
VALUE IN HEALTH
IF
6
2012-05-01
93
OA
AI
Gnanasakthy, Ari; Mordin, Margaret; Clark, Marci; DeMuro, Carla; Fehnel, Sheri; Copley-Merriman, Catherine
分享
收藏
CHRONIC KIDNEY DISEASE BURDENS PATIENTS, HEALTH CARE SYSTEMS, AND EMPLOYERS
VALUE IN HEALTH
IF
6
2011-11-01
0
OA
AI
Davis, K.; Sood, V; Hogue, S.; Braun, L. A.; Copley-Merriman, C.; Lieberman, B.
分享
收藏
CLINCAL AND ECONOMIC EVIDENCE BASES FOR HEALTH TECHNOLOGY ASSESSMENT: A COMPARISON OF THREE JURISDICTIONS
VALUE IN HEALTH
IF
6
2011-11-01
0
PRE
AI
Walter, J. W.; Spinner, D. S.; Birt, J.; Bowman, L.; Mauskopf, J.; Drummond, M.; Copley-Merriman, C.
分享
收藏
研究方向
暂时未获取到该数据
合作学者
合作期刊
W
William H. Herman
H 指数: 106 · 论文数: 668
M
Michael Drummond
H 指数: 75 · 论文数: 592
D
David Osoba
H 指数: 71 · 论文数: 276
K
Keith L. Davis
H 指数: 61 · 论文数: 401
C
Catherine C. Cowie
H 指数: 60 · 论文数: 168
查看更多